Canaccord Genuity Maintains a 'Buy' on WebMD Health (WBMD); Lowering Numbers
Tweet
Share
E-mailGet Alerts WBMD Hot Sheet
Price: $66.48 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on WebMD Health Corp. (NASDAQ: WBMD), PT lowered to $44.
Canaccord analyst, Heath Terry, said, "WebMD pre-announced Q2 results by roughly confirming prior guidance, and lowered F2011 guidance (Figure 1) as pharma and CPG programs planned for the second half were cancelled or delayed. We are lowering our H2 estimates and price target to reflect the ambiguous regulatory environment and the uncertainty around the company’s efforts to build a meaningful CPG business...We’re revising our F2011 estimates from revenues/EPS of $639M/$1.38 to $593M/$1.12, while our F2012 estimates go from $746M/$1.46 to $650M/$1.01."
For more ratings news on WebMD Health Corp. click here and for the rating history of WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $32.48 yesterday.
Canaccord analyst, Heath Terry, said, "WebMD pre-announced Q2 results by roughly confirming prior guidance, and lowered F2011 guidance (Figure 1) as pharma and CPG programs planned for the second half were cancelled or delayed. We are lowering our H2 estimates and price target to reflect the ambiguous regulatory environment and the uncertainty around the company’s efforts to build a meaningful CPG business...We’re revising our F2011 estimates from revenues/EPS of $639M/$1.38 to $593M/$1.12, while our F2012 estimates go from $746M/$1.46 to $650M/$1.01."
For more ratings news on WebMD Health Corp. click here and for the rating history of WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $32.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- New Street Research Upgrades Micron Technology (MU) to Buy
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
